Digoxin loading doses for atrial fibrillation in critically Ill patients

30 August 2024 (15:00 - 15:50)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Tania Ahuja

NYU Grossman School of Medicine, New York (United States of America)

7 More presentations in this session

Presentation thumbnail

Adverse cardiovascular outcomes due to potential drug-drug interactions in statin therapy: a population-based study

Ms A. Lai (Shatin, HK)

Abstract Slides Video

Presentation thumbnail

Modulation of p300 acetylation to protect against doxorubicin-induced cardiotoxicity

Mr J. Lee (Toronto, CA)

Abstract Slides Video

Presentation thumbnail

Development of a cardiotoxicity evaluation system using a Heart-on-a-Chip Microdevice with aligned fiber device

Doctor K. Murata (Kobe, JP)

Abstract Slides Video

Presentation thumbnail

Drug-drug interactions of empagliflozin and dapagliflozin

Professor C. Stoellberger (Wien, AT)

Abstract Slides Video

Presentation thumbnail

Pregnancy protection in women of child-bearing age prescribed ACE inhibitors, ARBs or statins - A nationwide cohort study

Mr S. Nielsen (Hellerup, DK)

Abstract Slides Video

Access the full session

Session thumbnail

Drug interactions, efficacy, and safety

The Event

Event poster

ESC Congress 2024

30 August 2024 15:00 CET

You may be interested in

Congress Presentation

Utilization and safety of digoxin in patients with chronic heart failure and atrial fibrillation with rapid ventricular rate

Congress Presentation

Serum digoxin concentrations in patients with heart failure: a post-hoc analysis of the BIOSTAT-CHF study

Congress Presentation

The influence of digoxin on outcomes in remotely monitored patients with implantable cardioverter-defibrillators

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources